156 related articles for article (PubMed ID: 2183918)
21. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
22. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; Thompson KH; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and efficacy evaluation of a new anti-diabetic vanadyl(II) thiamine hydrochloride complex in streptozotocin-induced diabetic rats.
Ahmed El-Shazly S; Ahmed MM; Ibrahim ZS; Refat MS
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):227-39. PubMed ID: 25816395
[TBL] [Abstract][Full Text] [Related]
24. Effects of vanadyl sulphate on glucose homeostasis in severe diabetes induced by streptozotocin in rats.
Dehghani GA; Ahmadi S; Omrani GR
Indian J Med Res; 1997 Nov; 106():481-5. PubMed ID: 9415745
[TBL] [Abstract][Full Text] [Related]
25. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
26. Vanadium and diabetes.
Poucheret P; Verma S; Grynpas MD; McNeill JH
Mol Cell Biochem; 1998 Nov; 188(1-2):73-80. PubMed ID: 9823013
[TBL] [Abstract][Full Text] [Related]
27. Improvement of diabetic states in streptozotocin-induced type 1 diabetic rats by vanadyl sulfate in enteric-coated capsules.
Fugono J; Yasui H; Sakurai H
J Pharm Pharmacol; 2005 May; 57(5):665-9. PubMed ID: 15901357
[TBL] [Abstract][Full Text] [Related]
28. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
[TBL] [Abstract][Full Text] [Related]
29. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
[TBL] [Abstract][Full Text] [Related]
30. Effect of vanadium compounds on calmodulin activity in experimental diabetes in rats.
Aktan F; Nebioglu S
Can J Physiol Pharmacol; 1994 Jul; 72(7):753-8. PubMed ID: 7828083
[TBL] [Abstract][Full Text] [Related]
31. The effect of oral vanadyl treatment on the reactivity of tracheal smooth muscle obtained from insulin-dependent diabetic rats.
Ozansoy G; Karasu C; Ozçelikay AT
Gen Pharmacol; 1993 Jan; 24(1):115-9. PubMed ID: 8482485
[TBL] [Abstract][Full Text] [Related]
32. Effect of Vanadyl Rosiglitazone, a New Insulin-Mimetic Vanadium Complexes, on Glucose Homeostasis of Diabetic Mice.
Jiang P; Dong Z; Ma B; Ni Z; Duan H; Li X; Wang B; Ma X; Wei Q; Ji X; Li M
Appl Biochem Biotechnol; 2016 Nov; 180(5):841-851. PubMed ID: 27240663
[TBL] [Abstract][Full Text] [Related]
33. Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment.
Ramanadham S; Brownsey RW; Cros GH; Mongold JJ; McNeill JH
Metabolism; 1989 Oct; 38(10):1022-8. PubMed ID: 2677609
[TBL] [Abstract][Full Text] [Related]
34. Long-term antidiabetic activity of vanadyl after treatment withdrawal: restoration of insulin secretion?
Cros GH; Cam MC; Serrano JJ; Ribes G; McNeill JH
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):191-5. PubMed ID: 8927038
[TBL] [Abstract][Full Text] [Related]
35. In vivo insulin resistance in streptozotocin-diabetic rats--evidence for reversal following oral vanadate treatment.
Blondel O; Bailbe D; Portha B
Diabetologia; 1989 Mar; 32(3):185-90. PubMed ID: 2666209
[TBL] [Abstract][Full Text] [Related]
36. Normalization of hyperglycaemia by oral vanadyl sulfate does not reverse diabetes-induced protection against cisplatin nephrotoxicity in streptozotocin-diabetic rats.
Sarangarajan R; Cacini W
Pharmacol Toxicol; 1999 Oct; 85(4):169-73. PubMed ID: 10563515
[TBL] [Abstract][Full Text] [Related]
37. Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R; Giridhar R; Yadav MR
J Trace Elem Med Biol; 2005; 18(3):211-7. PubMed ID: 15966569
[TBL] [Abstract][Full Text] [Related]
38. Conformation changes in brain calcineurin in diabetic rats with or without treatment with vanadyl sulfate.
Li H; Wei Q
IUBMB Life; 2001 Jun; 51(6):373-6. PubMed ID: 11758805
[TBL] [Abstract][Full Text] [Related]
39. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Tunali S; Yanardag R
Pharmacol Res; 2006 Mar; 53(3):271-7. PubMed ID: 16431126
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
Yao J; Battell ML; McNeill JH
Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
